Introduction {#sec1}
============

The pulmonary circulation is regulated to optimize respiratory gas exchange. Various factors affect pulmonary vascular reactivity, including neural, hormonal, inflammatory, and local mediators. Autonomic innervation of the pulmonary vasculature has been documented in various mammals although there is significant variation in the distribution of the nerves ([@ref4]). Considerable evidence also indicates there is a greater density of autonomic nerve fibers in larger vessels and vascular branching points ([@ref11]). The functional significance of sympathetic innervation of the human lung is not well understood although both α- and β-adrenergic receptors (ARs) are expressed in the pulmonary vascular bed. α-AR function predominates, however, in the fetal circulation with a higher basal vasomotor tone and greater reactivity to α-adrenergic stimulation ([@ref45]). Notably, long-term hypoxia (LTH) results in upregulation of α~1~-AR gene transcription ([@ref59]).

Pulmonary vasoconstriction and high pulmonary vascular resistance, principally owing to a relatively low oxygen tension, are hallmarks of the fetal circulation. The high vascular resistance reduces energy expenditure to an organ that does not serve its primary purpose *in utero* ([@ref70]). LTH during gestation due to high-altitude living, smoking, maternal anemia, placental insufficiency, or other causes is detrimental to the fetus and causes pulmonary hypertension and other complications in the newborn ([@ref48]). However, the underlying mechanisms remain largely elusive.

Previously, we demonstrated in sheep that LTH increased norepinephrine-induced contractions in pulmonary arteries and decreased acetylcholine-mediated relaxations in pulmonary veins ([@ref73]). Other studies showed that phenylephrine (PE)-induced contractions were increased in endothelium intact but not denuded, pig pulmonary arteries exposed to hypoxia ([@ref49]). We also demonstrated that PE-induced cytosolic Ca^2+^ responses were similar in pulmonary arterial myocytes from fetal and adult sheep ([@ref22]). Nonetheless, little is known regarding the impact of LTH in the fetal and adult periods on adrenergic-mediated contractions or the underlying receptor-induced Ca^2+^ signals. The aim of the current studies was to determine the influence of long-term hypoxic stress on α-AR-dependent pulmonary arterial contractility. We tested the hypothesis that LTH in the fetal and adult periods enhance α-AR-dependent pulmonary arterial contractility. This was evaluated in intact arterial segments from fetal and adult sheep that lived at low altitude or were exposed to high-altitude hypoxia for 110+ days.

Materials and Methods {#sec2}
=====================

Experimental Animals {#sec3}
--------------------

Animal handling was performed as per our previous studies over the past two decades including numerous studies on vessels of the pulmonary vasculature. Sheep were chosen for study because of their similar developmental profile to human infants, especially with regards to their lung development ([@ref52]; [@ref12]). Secondarily, the changes in lung structure and function are somewhat mild relative to other species and again similar to humans ([@ref52]). Non-pregnant and pregnant ewes born at low altitudes were purchased from Nebeker Ranch (Lancaster, CA; 720 m) and transported to the Loma Linda University (353 m; arterial PaO~2~ = 95 ± 5 Torr) or were transported and acclimatized to high altitude (3,801 m, PaO~2~ = 60 ± 5 Torr) at the Barcroft Laboratory, White Mountain Research Station (Bishop, CA) for approximately 110 days ([@ref37]; [@ref41]). Previous studies show that the PaO~2~ of fetal animals exposed to this level of hypoxia was roughly 20 Torr ([@ref37]; [@ref52]). Animals acclimatized to high altitude were transported to the Loma Linda University, and shortly after arrival, a tracheal catheter was placed in the ewe, through which N~2~ flowed at a rate adjusted to maintain PaO~2~ at \~60 Torr ([@ref38]) until the time of the experimental study. Arterial blood gasses were monitored in the hypoxic animals several times each day and the N~2~ flow rate adjusted as needed to regulate maternal PaO~2~. Within 1--5 days after arriving at the university, anesthesia was induced with Ketamine (10 mg/kg IV) and Midazolam (5 mg/kg IV).The ewe was then placed in the supine position, intubated, and anesthesia maintained by inhalation of 1.5--2.5% Isoflurane in oxygen. Following tissue collection, sheep were sacrificed by intravenous injection of the proprietary euthanasia solution, Euthasol (2 ml/kg; Virbac, Ft. Worth, TX, USA). All tissue bath and calcium experimental procedures were performed as previously described ([@ref26]; [@ref54], [@ref53]; [@ref6]; [@ref63]) within the regulations of the Animal Welfare Act, the National Institutes of Health Guide for the Care and Use of Laboratory Animals, "The Guiding Principles in the Care and Use of Animals" approved by the Council of the American Physiological Society, and the Animal Care and Use Committee of the Loma Linda University. Although the animals were housed in a rarified environment at the White Mountain Research Station and then the low PaO~2~ was maintained at the Loma Linda University by breathing hypoxic gasses, all experimental studies were performed under normoxic conditions at the Loma Linda University. This differs from studies performed by researchers in Chile who use sheep housed at the Putre Research Station, International Center for Andean Studies at 3,600 m above sea level ([@ref32], [@ref33]). In comparison to work by researchers performed at Putre on sheep and other high-altitude research stations using various other animal models ([@ref52]; [@ref12]), our studies identify those changes and mechanisms that persist in low-altitude environments following high-altitude living and gestation. Our work using terrestrial high-altitude exposure also differs from studies performed on sheep exposed to hypoxia in chambers that have relatively short exposure periods ([@ref1]; [@ref46]). When comparing the terrestrial and chamber models of exposure, the long durations of our exposures would restrict the number of sheep that could be examined each year. Tissues from a total of 106 experimental animals were examined for the studies of this report. This includes 22 adult normoxic (AN), 26 adult hypoxic (AH), 36 fetal normoxic (FN), and 25 fetal hypoxic (FH) animals. The long duration of exposure combined with the large numbers of animals used in our studies makes such chamber studies or performing studies at the White Mountain field station largely impractical. Even still, we are also fully aware that other phenomenon and mechanisms could be unmasked by performing studies at high-altitude research laboratories, such as the augmented hypoxic pulmonary vascular pressures we previously reported in 2-week-old newborn lambs born at high altitude ([@ref5]).

Tissue Preparation {#sec4}
------------------

Pulmonary arteries were dissected immediately from isolated lungs for contractility experiments from non-pregnant adult ewes or fetuses under normoxic conditions. Fourth and fifth order pulmonary arteries with internal diameters of about 500--700 μm were dissected free of parenchyma and cut into 5 mm long rings in ice-cold phosphate free balanced salt solution of the following composition (mM): 126 NaCl; 5 KCl; 10 HEPES; 1 MgCl~2~; 2 CaCl~2~; 10 glucose; pH 7.4 (adjusted with NaOH). To avoid complications from endothelium-mediated effects, the endothelium was disrupted by carefully rotating the artery on a small roughened hypodermic needle or on the mounting wire ([@ref54]).

Contraction Studies {#sec5}
-------------------

Pulmonary arterial contraction studies were performed as previously described at the Loma Linda University at 353 m ([@ref6]; [@ref19]). In brief, pulmonary arterial rings on tungsten wires were suspended in organ baths (Radnoti Glass Instruments, Inc. Monrovia, CA) that contained 5 or 10 ml of modified Krebs-Henseleit solution containing in mM: 120 NaCl; 4.8 KCl; 1.2 K~2~HPO~4~; 25 NaHCO~3~; 1.2 MgCl~2~; 2.5 CaCl~2~; 10 glucose. The bath solution was maintained at 37°C and aerated with 95% O~2~ to 5% CO~2~ (pH = 7.4). The wires were attached to low compliance force transducers (Radnoti Glass Instruments Inc.) for the measurement of isometric force ([@ref6]; [@ref19]) that were connected to an analogue to digital data interface (Powerlab 16/30 A/D Instruments, Colorado Springs, CO; or MP100, Biopac, Goleta, CA) attached to a computer. The changes in tension were recorded using Chart 5.5 (AD Instruments, Colorado Springs, CO) or AcqKnowledge 3.9 (Biopac, Systems, Inc., Goleta, CA) and analyzed *post hoc*. Vessels were equilibrated without tension for a minimum of 30 min and tensioned to approximately 0.75 g ([@ref26]; [@ref54]; [@ref6]). Arterial tension was normalized to a maximum response obtained with 125 mM KCl (high K^+^) (%T~Kmax~) or 10 μM serotonin (%T~5HTmax~). For evaluating dose-response characteristics, arteries were stimulated by applying 1 nM to 100 μM phenylephrine or 100 pM to 10 μM dexmedetomidine (DMT) logarithmically without washing in-between each concentration increase. [Figure 1](#fig1){ref-type="fig"} studies were based on arterial segments isolated from normoxic fetal (9), adult (8) and hypoxic fetal (11), and adult (12) animals, which served as the controls for the pharmacological studies outlined in [Figures 2](#fig2){ref-type="fig"}, [4](#fig4){ref-type="fig"}. [Figure 2](#fig2){ref-type="fig"} studies were based on arteries isolated from normoxic fetal prazosine (3) and yohimbine (5); adult prazosine (4) and yohimbine (4); as well as hypoxic fetal prazosine (4) and yohimbine (4); adult prazosine (4) and yohimbine (4). [Figure 3](#fig3){ref-type="fig"} studies were based on arteries isolated from fetal normoxic animals for control (3) and yohimbine (4) studies. [Figure 4](#fig4){ref-type="fig"} studies were based on arteries isolated from normoxic fetal CEC (4), WB (4), and BMY (4); adult CEC (5), WB (4), and BMY (5); as well as hypoxic fetal CEC (4), WB (4), and BMY (4); adult CEC (4), WB (4), and BMY (4). [Figure 5](#fig5){ref-type="fig"} measurements were made in six animals from each group except for the fetal normoxic group, which was based on tissues from seven animals. [Figure 6](#fig6){ref-type="fig"} recordings were made in three adult normoxic, three adult hypoxic, five fetal normoxic, and three fetal hypoxic animals.

![Phenylephrine-mediated contraction of pulmonary arteries from sheep is depressed in the adult period and enhanced by LTH. **(A)** Dose-response curves of pulmonary arterial rings exposed to 1 nM to 100 μM of phenylephrine in an additive manner from normoxic (solid lines) and LTH (dashed lines) fetal (gray lines and boxes) and adult (black lines and circles) sheep. Curves are plotted in relation to the maximal contraction induced by initial stimulation of 125 mM K^+^ Krebs-Henseleit solution (%T~Kmax~). **(B)** Maximum contraction relative to %T~Kmax~. **(C)** Log EC~50~ for phenylephrine induced contraction. **(D)** Area under the dose-response curve relative to high K^+^ contraction. **(E)** Absolute force developed for 100 μM phenylephrine-induced contraction. Points and bars are mean values and error bars indicate ± S.E.M. Comparisons between groups were made using a two-way ANOVA with a Bonferroni *post hoc* analysis (^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001). Numbers of animals for each group are provided in the "Methods" section.](fphys-10-01032-g001){#fig1}

![Phenylephrine-induced contraction is largely dependent on α~1~-adrenergic contraction. **(a)** Dose-response curves of pulmonary arterial rings exposed to 1 nM to 100 μM phenylephrine in an additive manner from normoxic and LTH, fetal **(A,B)** and adult **(C,D)** sheep. Solid lines with circles indicate vehicle-control (DMSO) while long dashes and squares indicate 10 nM prazosin and triangles and short dashes indicate 100 nM yohimbine. Log agonist vs. response curves are plotted in relation to the maximal contraction induced by initial stimulation of 125 mM K^+^ Krebs-Henseleit solution (%T~Kmax~). **(b)** Log EC~50~ for phenylephrine-induced contraction. **(c)** Maximum contraction relative to %T~Kmax~. **(d)** Area under the dose-response curve relative to high K^+^ contraction. Points and bars are mean values while error bars indicate ± S.E.M. Comparisons of drug treated arteries to control were made using a one-way ANOVA with a Newman-Keuls multiple comparison test (^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001). Numbers of animals for each fetal and adult group are provided in the "Methods" section and in **(b)**.](fphys-10-01032-g002){#fig2}

![Dexmedetomidine causes contraction and relaxation of normoxic fetal pulmonary arteries. Dose-response curves of pulmonary arterial rings exposed to 100 pM to 10 μM of dexmedetomidine in an additive manner from normoxic fetal sheep in the absence **(A)** and presence **(B)** of 10 μM serotonin. Gray lines and triangles are for dexmedetomidine contraction **(A)** or relaxation **(B)** in the presence of yohimbine, and black lines and boxes are for dexmedetomidine contraction **(A)** or relaxation **(B)** in the presence of vehicle-control (DMSO). Solid lines indicate log agonist vs. response curves that are plotted in relation to the maximal contraction induced by initial stimulation of **(A)** 125 mM K^+^ Krebs-Henseleit solution (%T~Kmax~) or **(B)** 10 μM serotonin. Points and error bars indicate mean ± S.E.M. Numbers of animals for each group are provided in the "Methods" section.](fphys-10-01032-g003){#fig3}

![α~1A~-AR and α~1B~-AR antagonists preferentially block phenylephrine-induced pulmonary vascular contractility. **(a)** Dose response curves of pulmonary arterial rings exposed to 1 nM to 100 μM phenylephrine in an additive manner from normoxic and LTH, fetal **(A,B)** and adult **(C,D)** sheep. Curves of log agonist vs. response were repeated in the absence (circles and solid lines) or presence of 10 μM CEC (α~1B~-AR blocker, squares and long dashed lines), 100 nM WB (α~1A~-AR blocker, triangles and short dashed lines) or 100 nM BMY (α~1D~-AR blocker, upside down triangles and dashed and dotted lines) for normoxic and LTH, fetal **(A,B)** and adult **(C,D)** sheep pulmonary arteries. **(b)** Log EC~50~ for phenylephrine induced contraction. **(c)** Maximum contraction relative to high K^+^. **(d)** Area under the dose-response curve relative to high K^+^ contraction. Points and bars are mean values while error bars indicate ± S.E.M. Comparisons of drug treated arteries to control were made using a one-way ANOVA with a Newman-Keuls Multiple Comparison Test (^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001). Numbers of animals for each fetal and adult group are provided in the "Methods" section and **(b)**.](fphys-10-01032-g004){#fig4}

![LTH in the fetal and adult periods have unique impact on mRNA expression of alpha adrenergic receptors. Presented are the raw Cycle threshold (Ct) values from real time quantitative PCR measurements for **(A)** Alpha 1a AR, **(B)** Alpha 1b AR, **(C)** Alpha 1d AR, and **(D)** GAPDH. Normalization was to input RNA, all PCR reactions used input cDNA derived from 5 ng of total RNA. Bars and error bars represent the mean ± S.E.M. Significant differences between groups were established using a two-way ANOVA with a Bonferroni *post hoc* analysis (^\*^*p* \< 0.05, ^\*\*^*p* \< 0.01, ^\*\*\*^*p* \< 0.001). Numbers of animals for each group are provided in the methods section.](fphys-10-01032-g005){#fig5}

![Impact of LTH in the fetal and adult periods on unstimulated and PE-mediated whole-cell Ca^2+^ responses in pulmonary arterial myocytes. Shown are representative fluorescent images at time points shown by the arrow and the traces of fractional Fluo-4 fluorescence for unstimulated **(A)** and 10 μM phenylephrine stimulated **(B)** arteries. **(C)** Percentage of myocytes in a 1,000 μm^2^ area that had Ca^2+^ responses to 10 μM PE under unstimulated (open circles) and stimulated (filled circles) conditions based on the number of runs examined. Colored circles on each image correspond to the placement of regions of interest for the traces of the same color in the tracing. About 10 μM phenylephrine was present during the time period denoted by the horizontal bar. Images were made with a 20× non-immersion objective (NA 0.8). Scale bar is 25 μm. Numbers of animals for each group are provided in the "Methods" section.](fphys-10-01032-g006){#fig6}

RNA Purification {#sec6}
----------------

To obtain RNA of adequate quality for qPCR analysis from fibrous sheep arteries, a protocol combining the Qiagen® Fibrous Tissue RNeasy kit (Qiagen, Germantown, MD) with a Bullet blender (Next Advance Inc.) was developed for mid-sized pulmonary arteries as described below. Notably, the α-AR subtypes in native tissue were expected to have low expression ([@ref47]; [@ref61]), increasing concerns about the accuracy of the qPCR measurements. A 450 μl aliquot of buffer RLT with Mercaptoethanol was placed into the RNAse-free Blue Rhino Bead beating tube at room temperature. RNA later treated vessels that were frozen in liquid N~2~ and stored at −80°C were then placed into the tube and the bullet blender unit was run for 3 min at maximum setting. Subsequently, 885 μl RNase-free H~2~O and 15 μl of protease K were added, and samples were then mixed and incubated at 55°C in a water bath for 10--11 min. Sample tubes were then spun at 10,000 × *g* for 3 min at room temperature and the supernatant transferred to RNase free tubes followed by addition of 0.5 vol. of Mol. Bio grade absolute EtOH. The samples were loaded onto RNeasy columns and the fibrous tissue protocol completed with on-column DNAse treatment and elution using two 30 μl additions of RNAse-free H~2~O. RNA concentrations were quantified by Nanodrop and RNA integrity demonstrated on bleach agarose gels ([@ref3]). For all samples, the large RNA subunit was clearly predominant relative to the smaller subunit, presenting the appearance of RNA previously demonstrated to have RIN values between 7 and 8. The final RNA samples were aliquoted, frozen in liquid N~2~, and stored at −80°C.

Reverse Transcription {#sec7}
---------------------

The QuantiTect Reverse Transcription Kit (Qiagen), which incorporates a second DNAse treatment, was used according to the manufacturer recommended protocol. This included 400 ng input RNA for each 10 μl RT reaction. All reactions were set up on ice to minimize the risk of RNA degradation. Control experiments without reverse transcriptase confirmed that the cDNA samples did not have any genomic sequence contamination as judged by the absence of target product in trans-intron qPCR reactions.

Analysis of mRNA levels was based on the CFX96 Real-Time PCR Detector and software (Biorad, Hercules CA). All qPCR reactions used cDNA derived from 5 ng of reverse transcribed total RNA. Multiple primer pairs were tested to establish the most reliable primers for each receptor subtype based on PCR efficiency, linearity within the analytic range, and localization within essential coding sequence in the second exon of common subtype isoforms. The best primer pair for each subtype positioned within the essential coding sequence in the second exon of common isoforms ([@ref31]) was used for qPCR quantitation. These primers included those targeted to: adra1a Forward, ATACCCATGCTCCAGTCAAG; Reverse, GTGTTTGGAGGACTGCTTTC. adra1b Forward, TGTTCAAGGTGGTCTTCTGG; Reverse, GCTTGAACTCCTTGCTGGA. adra1d Forward, AGGGCGTCTTCAAGGTTATC; Reverse, CAGGGGTAGATGAGTGGATT. GAPDH, Forward, TGGAAATGTATGGAGGTCGG; Reverse, GGAAGAGAGAGTTCCTCAGC.

Initial experiments included both β-actin and GAPDH as potential internal load corrections; however, all applications of the ∆∆Ct approach produced increased variance consequently, normalization was to input cDNA (derived from 5 ng total RNA), and statistical analysis was based on raw, average Ct values produced by three qPCR quantifications on separate days. For each experiment, singly frozen sub-aliquots of sheep genomic DNA (Amsbio LLC) were used as a reference to estimate transcript copies per cell for each of the three α~1~-AR subtypes. Quantitative estimates of copy number were based on ∆Ct from 316 double strand copies assuming one cycle represented a two-fold change in copy number. Estimates of mRNA copies per cell are based on the assumption of 20 pg total RNA per cell, which implies 5 ng input total RNA representing \~250 cells.

Calcium Imaging {#sec8}
---------------

Cytosolic calcium was measured in pulmonary arterial myocytes *in situ* using an *en face* preparation in balanced salt solution at the Loma Linda University, as we have recently described ([@ref26]; [@ref54]; [@ref6]). In brief, tissues were loaded with the Ca^2+^ sensitive dye Fluo-4 AM (10 μM, Invitrogen, Carlsbad, CA, USA) with 0.1% pluronic F127 for 1.5--2 h at room temperature in the dark and measurements made with a Zeiss 710 NLO laser scanning confocal imaging workstation (Thornwood, NY) mounted to an inverted microscope (Zeiss AxioObserver A1). Arterial segments were then washed for 30 min, cut into linear strips, pinned to sylgard blocks (Ellsworth Adhesives, Germantown, WI), placed in an open bath imaging chamber (Warner Instruments, Hamden, CT), and mounted *en face* on the confocal imaging stage. Arteries were perfused at approximately 1 ml/min using a peristaltic pump (Rainin, Oakland, CA) with an electronic pinch valve system (Automate Scientific, Berkeley, CA). Cells were illuminated at 488 nm with a krypton argon laser, and the emitted light was collected using a photomultiplier tube (frames of 512 × 512 pixels) and a prismatic defractor (wavelengths of 493--622 nm). Full frame images were generated every 1 s. The pinhole was adjusted to provide an imaging depth of \~10 μm, which is roughly equivalent to the width of two cells ([@ref26]; [@ref54]). Images were acquired at a 16-bit sampling depth using a non-immersion 20× Plan Apochromat (numerical aperture, NA 0.8). Regions of interest were examined *post hoc*, and although attempts were made to analyze, the oscillations in fluorescent intensity from recordings using LCPro quantification could not be adequately performed due to significant vasomotion during PE stimulation ([@ref15], [@ref16]). Because of the substantial vessel reactivity, the numbers of arterial myocytes with Ca^2+^ events due to phenylephrine were recorded and the percentage of active myocytes calculated by comparing to the numbers of cells with observable Flou-4 fluorescence in the region of interest ([@ref26]; [@ref54]). The number of observable cells examined for [Figure 6C](#fig6){ref-type="fig"} in each 1,000 μm^2^ region were as follows: Adult Normoxic, AN, 6.6 ± 0.3; Adult Hypoxic, AH, 8.3 ± 0.6; Fetal Normoxic, FN, 7.6 ± 0.4; Fetal Hypoxic, FH, 7.0 ± 0.2.

Chemicals and Drugs {#sec9}
-------------------

Most reagents and chemicals were purchased from Sigma-Aldrich (St. Louis, MO) except dexmedetomidine which was purchased from Tocris and other chemicals and reagents as noted.

Statistical Methods {#sec10}
-------------------

All time-series recordings were graphed, and statistical analyses were made using GraphPad Prism 5.0 (La Jolla, CA) with the data presented as mean ± S.E.M. Data for bar plots were examined for normality with a D'Agostino and Pearson omnibus normality test. For most contractility, confocal, and PCR studies, comparisons were made within and among groups using either a two-way ANOVA and Bonferroni *post hoc* analyses or a one-way ANOVA with a with a Newman-Keuls Multiple Comparison Test. Categorical data shown in [Figure 6C](#fig6){ref-type="fig"} were analyzed by a chi-square test. Dose-response curves were fitted in Prism 5.0 using a Hill equation ([@ref26]; [@ref54]; [@ref6]). Comparisons of the non-linear fit data for the influence of yohimbine on serotonin contraction, [Figure 3A](#fig3){ref-type="fig"} were examined by an extra sum of squares F-test. The *N* values reported reflect the total number of regions of interest, arterial segments, and/or total number of sheep tested as delineated elsewhere in the methods, figure legends, and [Table 1](#tab1){ref-type="table"}. *p* \< 0.05 was accepted as statistically significant.

###### 

Chronic hypoxia, maturation and adrenergic receptor and GAPDH mRNA expression.

  Group    Mean ± SEM        *N*   Fold change   mRNA copies per cell
  -------- ----------------- ----- ------------- ----------------------
  Adra1a                                         
  FN       27.79 ± 0.51      7     1.00          0.40
  FH       28.13 ± 0.40      6     0.79          0.32
  AN       26.77 ± 0.32      6     2.03          0.81
  AH       26.35 ± 0.41a     6     2.73          1.09
  Adra1b                                         
  FN       31.60 ± 0.31      7     1.00          0.63
  FH       30.77 ± 0.28      6     1.78          1.12
  AN       30.50 ± 0.45a     6     2.15          1.35
  AH       29.54 ± 0.21a     6     4.19          2.65
  Adra1d                                         
  FN       25.62 ± 0.32      7     1.00          2.29
  FH       24.81 ± 0.32      6     1.75          4.00
  AN       24.26 ± 0.23a     6     2.56          5.86
  AH       22.95 ± 0.25a,b   6     6.35          14.54
  GAPDH                                          
  FN       20.84 ± 0.24      7     1.00          20.1
  FH       19.89 ± 0.27b     6     1.94          39.1
  AN       20.11 ± 0.07a     6     1.66          33.4
  AH       19.65 ± 0.12      6     2.29          46.1

*qPCR data presented as raw Ct values produced by 5 ng input RNA as shown graphically in [Figure 5](#fig5){ref-type="fig"}. N indicates the number of animals for each condition in each group. Fold change is calculated relative to FN condition for each group. mRNA copies/cell estimated as described in methods. Significance established using two-way ANOVA with Bonferroni post hoc analysis. a -- significant relative to normoxic fetus, b -- significant compared to normoxic counterpart. Actual p's are provided in [Figure 5](#fig5){ref-type="fig"}*.

Results {#sec11}
=======

Maturation and Long-Term Hypoxia Influence Alpha-Adrenergic-Dependent Reactivity {#sec12}
--------------------------------------------------------------------------------

The first series of experiments were designed to compare the effects of LTH in the fetal and adult periods on sympathetic-induced contractions of pulmonary arteries. This was achieved by examining the influence of cumulative doses of the selective α-AR agonist phenylephrine on contractions of pulmonary vascular rings isolated from adult and fetal sheep housed in either normoxic or LTH conditions. Phenylephrine was chosen *in lieu* of norepinephrine because the latter activates β-ARs that are expressed in pulmonary arteries ([@ref35]; [@ref44]). [Figure 1](#fig1){ref-type="fig"} depicts summarized data for dose-response curves that were produced from these experiments. For all groups, arterial contractions in response to PE displayed a sigmoidal dose-response relationship ([Figure 1A](#fig1){ref-type="fig"}) and similar EC~50~'s ([Figure 1C](#fig1){ref-type="fig"}), indicating that neither development nor LTH modified the potency of PE. However, the maximum contraction relative to high potassium in the adult period for normoxic sheep was significantly reduced relative to fetus as shown in [Figure 1B](#fig1){ref-type="fig"}. While LTH had no effect on fetal pulmonary arterial contractions, it elevated the maximum contraction in the adult period to near fetal levels as illustrated in [Figure 1B](#fig1){ref-type="fig"} and in the area under the curve as shown in [Figure 1D](#fig1){ref-type="fig"}. Although maximal contraction relative to T~Kmax~ was lower in adult compared to fetus ([Figure 1B](#fig1){ref-type="fig"}), the absolute contractile force due to phenylephrine was higher in the adult ([Figure 1E](#fig1){ref-type="fig"}).

Maturation and Long-Term Hypoxia Impact the Role of α~1-~ Versus α~2~-Adrenergic Receptors to Arterial Contraction {#sec13}
------------------------------------------------------------------------------------------------------------------

Based on these results and the literature to date ([@ref39]; [@ref42]; [@ref44]; [@ref51]; [@ref21]), we performed a series of experiments in order to determine the contributions of α~1~- and α~2~-AR to pulmonary arterial contractions. This was achieved by repeating the dose-response curves for each of the four animal groups in the presence or absence of antagonists of α~1~-AR (10 nM prazosin) or α~2~-AR (100 nM yohimbine) ([@ref60]; [@ref20]). Data for these studies are shown in [Figure 2](#fig2){ref-type="fig"}. Prazosin had a similar effect in all four groups ([Figure 2](#fig2){ref-type="fig"}), causing a substantial rightward shift in the dose-response relationships ([Figures 2Aa](#fig2){ref-type="fig"}--[Da](#fig2){ref-type="fig"}) that translated into a reduced potency for PE in all groups ([Figures 2Ab](#fig2){ref-type="fig"}--[Db](#fig2){ref-type="fig"}). In comparison, prazosin had little or no effect on efficacy ([Figures 2Ac](#fig2){ref-type="fig"}--[Dc](#fig2){ref-type="fig"}). [Figures 2Ad](#fig2){ref-type="fig"}--[Dd](#fig2){ref-type="fig"} show that the area under the contractile curve was not as sensitive to prazosin or yohimbine as compared to the potency. Yohimbine caused a significant rightward shift in the PE-mediated contractility curve only in vessels from the fetal normoxic group ([Figure 1Ac](#fig1){ref-type="fig"}) but had no effect on PE-mediated contractions of adult vessels (normoxic and hypoxic) or fetal hypoxic vessels. These results suggest that α~2~-ARs may contribute to sympathetic contraction before birth and that antenatal hypoxia and the adult period suppress this role.

α~2~-Adrenergic Receptors Are Important to Contractile and Relaxation Responses in Fetal Normoxic Pulmonary Arteries {#sec14}
--------------------------------------------------------------------------------------------------------------------

Because yohimbine blocked PE-mediated contractions only in arteries from the normoxic fetal group, studies were performed to further delineate the potential influence of α~2~-AR activation on arterial contraction ([@ref62]; [@ref36]) as well as relaxation ([@ref44]) in the fetal normoxic group. Evaluation of vessel reactivity was achieved by stimulating normoxic fetal arteries with the selective α~2~-AR agonist, dexmedetomidine ([@ref66]). [Figure 3A](#fig3){ref-type="fig"} shows the dose-response curves for normoxic fetal arteries stimulated with increasing doses of dexmedetomidine in the absence or presence of yohimbine. Dexmedetomidine caused modest contractions with a maximal response of approximately one-fifth that induced by PE ([Figure 2A](#fig2){ref-type="fig"}). Yohimbine treatment shifted the dose-response curve for dexmedetomidine contraction by one-log to the right (−7.8 ± 0.25 vs. −6.9 ± 0.14, *p* \< 0.05). This confirms that α~2~-ARs are involved in vasomotor tone in the fetal pulmonary circulation, and this effect can be mitigated by α~2~-AR antagonists like yohimbine.

We then sought to evaluate the role of α~2~-AR to cause further contraction as occurs in pre-stimulated pulmonary vasculature of dog ([@ref62]) and rat aorta ([@ref50]), or whether the arteries will relax as described in pig pulmonary arteries ([@ref57]) and fetal sheep pulmonary vasculature ([@ref44]). [Figure 3B](#fig3){ref-type="fig"} shows the dose-response curves of fetal normoxic arteries treated with incremental doses of dexmedetomidine that were pre-stimulated with 10 μM serotonin. Our results illustrate that serotonin precontracted arteries relaxed in response to dexmedetomidine, an effect which was blocked by yohimbine. Taken together, these results indicate that inhibition of α~2~-AR does not seem to have a significant impact on phenylephrine-induced contraction in vessels from hypoxic animals from the fetal or adult periods but preferentially attenuates contractions in fetal normoxic vessels. However, activation of α~2~-AR in fetal normoxic vessels can cause vessel relaxation when arteries have significant serotonergic pretone.

α~1A~-, α~1B~-, and α~1D~-Adrenergic Receptors Have Selective Roles to Vessel Contraction {#sec15}
-----------------------------------------------------------------------------------------

The roles of the different α~1~-AR subtypes to the contraction responses shown in [Figures 1](#fig1){ref-type="fig"}, [2](#fig2){ref-type="fig"} were further delineated by performing PE dose-response contraction studies in the presence or absence of subtype selective α~1~-AR antagonists. The antagonists were chosen based on previously shown selectivity for the three α~1~-AR subtypes, namely α~1A~-AR (100 nM WB 4101), α~1B~-AR (10 μM CEC), and α~1D~-AR (100 nM BMY 7378) ([@ref25], [@ref23]). The results of these experiments are illustrated in [Figure 4](#fig4){ref-type="fig"}. Vessels from the fetal normoxic period were affected by the selective inhibitors of the three α~1~ subtypes, where the dose-response curves ([Figure 4Aa](#fig4){ref-type="fig"}) and corresponding EC~50~ ([Figure 4Ab](#fig4){ref-type="fig"}) were significantly rightshifted and the areas under the curve were decreased ([Figure 4Ad](#fig4){ref-type="fig"}). The efficacy of contraction ([Figure 4Ac](#fig4){ref-type="fig"}) was less sensitive than the other parameters, being reduced by inhibitors of α~1B~-AR and α~1D~-AR but not α~1A~-AR. Similarly, [Figure 4B](#fig4){ref-type="fig"} shows the influence of inhibitors on vessels from the fetal hypoxic period. All three inhibitors reduced the amplitude of contraction and area under the curve ([Figures 4Ba](#fig4){ref-type="fig"},[Bc](#fig4){ref-type="fig"},[Bd](#fig4){ref-type="fig"}). The potency of contraction, however, was rightshifted by inhibitors of α~1A~-AR and α~1B~-AR but not α~1D~-AR ([Figure 4Bb](#fig4){ref-type="fig"}).

Vessels from the adult normoxic period were sensitive to α~1A~-AR and α~1B~-AR but much less dependent on the α~1D~-AR. The EC~50~ was rightshifted by inhibitors of both α~1A~-AR and α~1B~-AR ([Figures 4Ca](#fig4){ref-type="fig"},[Cb](#fig4){ref-type="fig"}) while efficacy of contraction and area under the curve were each reduced by inhibition of α~1B~-AR ([Figures 4Cc](#fig4){ref-type="fig"},[Cd](#fig4){ref-type="fig"}). In comparison, contractility of arteries from the adult hypoxic period was affected by inhibitors of all three α~1~-AR receptors, but the effect for the α~1D~-AR was marginal. Although the amplitude was insensitive to the inhibitors ([Figure 4Dc](#fig4){ref-type="fig"}), the potency was rightshifted substantially by inhibitors of α~1A~-AR and α~1B~-AR and to a lesser extent by α~1D~-AR ([Figures 4Da](#fig4){ref-type="fig"},[Dc](#fig4){ref-type="fig"}). The area under the curve was reduced by inhibitors of α~1A~-AR and α~1B~-AR but not α~1D~-AR ([Figure 4Dd](#fig4){ref-type="fig"}).

mRNA Expression of α~1A~-, α~1B~-, and α~1D~-Adrenergic Receptor {#sec16}
----------------------------------------------------------------

Subsequently, qPCR was used to investigate subtype expression to determine if these patterns account for the changes observed in our functional studies of pulmonary arteries ([Figure 5](#fig5){ref-type="fig"} and [Table 1](#tab1){ref-type="table"}). Analysis of α~1A~-AR expression showed that message levels of this adrenergic receptor subtype did not increase with hypoxia in fetal or adult vessels but did increase in the adult period relative to fetus as shown in [Figure 5A](#fig5){ref-type="fig"} by decreased Ct values and by the increase in fold change and mRNA copies per cell ([Table 1](#tab1){ref-type="table"}). Statistical analysis was performed on raw Ct values because during assay development, attempts to apply the ∆∆Ct method using actin and/or GAPDH as internal controls were ineffective, as these corrections substantially increased variance. Further, GAPDH expression increased under hypoxic conditions in the fetus ([Figure 5D](#fig5){ref-type="fig"} and [Table 1](#tab1){ref-type="table"}), much as occurs in bovine endothelial cells ([@ref29]; [@ref28]). Of note, the tight clustering of GAPDH measurements for the normoxic adult suggest the variability observed in the other sample groupings reflects real differences in subunit expression. As for the α~1A~-AR, the α~1B~-AR and α~1D~-AR increased expression in the adult period relative to the fetus ([Figures 5B](#fig5){ref-type="fig"},[C](#fig5){ref-type="fig"} and [Table 1](#tab1){ref-type="table"}). The only significant difference due to hypoxia was an approximately 2.5-fold increase observed for α~1D~-AR in adult vessels.

Alpha-Adrenergic Receptor Generated Ca^2+^ Responses {#sec17}
----------------------------------------------------

The final series of studies examined the ability of PE to cause Ca^2+^ responses in myocytes that line the arterial wall. These studies were performed using an *en face* preparation with confocal laser scanning microscopy approaches such as we have used previously to examine serotonergic as well as caffeine-associated stimulation of Ca^2+^ responses in pulmonary arterial myocytes ([@ref26]; [@ref54]; [@ref30]). In the present study, cytosolic Ca^2+^ of the pulmonary arterial myocytes was monitored under unstimulated conditions and in response to addition of 10 μM PE. These studies were performed based on our prior experiments where PE caused cytosolic Ca^2+^ elevations in isolated myocytes from pulmonary arteries of fetal and adult sheep ([@ref22]). Moreover, these Ca^2+^ responses are likely coupled to pulmonary arterial contractions ([@ref25], [@ref26], [@ref23]; [@ref54]). The Ca^2+^-signaling behavior of the regions of interest are expressed as the average baseline-subtracted fractional fluorescence intensity tracing (F/Fo) over time and shown in the time series graphs in [Figures 6A](#fig6){ref-type="fig"},[B](#fig6){ref-type="fig"} in the presence of extracellular Ca^2+^. The bar above the tracing in [Figure 6B](#fig6){ref-type="fig"} shows when 10 μM PE was applied to the tissue. The images in [Figures 6A](#fig6){ref-type="fig"},[B](#fig6){ref-type="fig"} show *in situ* fluorescence micrographs of myocytes in the arterial wall isolated from normoxic fetal sheep for the time points as shown by the arrows in unstimulated ([Figure 6A](#fig6){ref-type="fig"}) and phenylephrine-stimulated ([Figure 6B](#fig6){ref-type="fig"}) conditions for the fluorescence intensity tracings in the panels shown on the right. Regions of interest are denoted by the small colored circles in the image panels and represent subcellular regions within individual myocytes that correspond to associated fluorescent time series data traces of the same color in [Figures 6A](#fig6){ref-type="fig"},[B](#fig6){ref-type="fig"}. [Figure 6A](#fig6){ref-type="fig"} illustrates that under unstimulated conditions, the Ca^2+^ oscillations are stochastic, occurring randomly during the recording. [Figure 6B](#fig6){ref-type="fig"} shows that stimulation with 10 μM PE causes deterministic Ca^2+^ responses among the arterial myocytes. [Figure 6C](#fig6){ref-type="fig"} shows the number of responsive cells in the arterial wall for the data recordings as determined by examining the number of myocytes with calcium responses in 33 μm × 33 μm boxes (1,000 μm^2^). The figure shows that there is some variability in the percentage of myocytes with Ca^2+^ oscillations under control conditions and in response to phenylephrine stimulation, though there are no significant differences due to stimulation or in the fetal or adult periods.

Discussion {#sec18}
==========

Summary of Findings {#sec19}
-------------------

The present study provides new information systematically comparing the effects of LTH in the fetal and adult periods on the functional changes for the role of α~1~- and α~2~-adrenergic receptors in the pulmonary vasculature. The contractile response to phenylephrine underwent significant changes from the fetal to adult periods and LTH caused further alterations. Of note, α~2~-ARs appeared to be important to vascular reactivity before birth in the normoxic fetal period; however, these α~2~-AR effects were not present in the adult period and were lost in fetuses exposed to LTH. We found there were significant roles for α~1A~- and α~1B~-ARs in pulmonary arterial contractions of all groups examined. There was also a lesser role for α~1D~-AR in the fetus that was reduced by hypoxia and largely absent in the adult period. Developmentally, the contractile properties produced by adrenergic stimulation are complex and take place in the context of changing vessel behavior due to LTH exposure.

Development and Alpha-Adrenergic Receptor Pulmonary Arterial Contractility {#sec20}
--------------------------------------------------------------------------

Developmental changes in adrenergic signaling of pulmonary arteries were expected given the dramatically different role these arteries play during the fetal period where blood flow is restricted as compared to the adult period where robust blood flow is required to exchange gasses. Given the need to maintain oxygenation in stressful situations, it is not surprising that adrenergic contractions during the adult period lessen relative to contractions due to depolarization with high K^+^. A similar reduction in adrenergic mediated contractions in the adult period occurs in the piglet, which has reduced norepinephrine mediated pulmonary vascular contractions following birth ([@ref60]). In this regard, our data showed that pulmonary vessels in adult sheep lost the contractile effects from both α~2~-AR activity and coupling to the α~1D~-AR, which were observed in the normoxic fetal period. Nevertheless, this relative decrease in contractility must be viewed in context as the absolute contractile force due to PE increased following birth. It is reasonable to suggest that the increased absolute force caused by PE is partly mediated through an increased expression of the α~1A~- and α~1B~-ARs. While it appears contradictory for the α~1D~-AR to play a minimal role in contractions of adult vessels given the 2.5-fold increases in its mRNA expression, α~1D~-AR levels do not necessarily correlate with arterial reactivity in arteries and instead contribute significantly to vascular remodeling in hypoxia-related pulmonary hypertension ([@ref13]).

Because autonomic innervation of the lung likely increases after birth, our data suggest that postnatal maturation may result in other functional changes ([@ref17]; [@ref65]; [@ref7]). Indeed, the process by which maturity into adulthood affects adrenergic dependent vascular contractility may be complex. One possibility is that during the adult period the increased sympathetic nerve stimulation may cause α adrenergic receptor desensitization and downregulation ([@ref17]; [@ref7]). Another explanation for decrements relative to high K^+^ during the adult period is that the sympathetic nerve supply may be trimmed. This tenant is supported by the lack of a profound difference in cellular Ca^2+^ signaling activity in fetal relative to adult pulmonary arterial myocytes.

Long-Term Hypoxia and Alpha-Adrenergic Receptor Pulmonary Arterial Contractility {#sec21}
--------------------------------------------------------------------------------

The LTH-induced enhancement of phenylephrine reactivity in pulmonary arteries of the adult period was expected. Chronic hypoxia in piglets prevents postbirth decreases in adrenergic tone ([@ref60]) and has been linked to hypoxia-induced pulmonary hypertension in multiple animal species including sheep ([@ref40]). This tie between adrenergic signaling and hypoxia-related pulmonary hypertension may be due to various factors. Hypertrophy of the smooth muscle layer in the small pulmonary arteries and arterioles appears to be a major determinant of pulmonary vascular responses to hypoxia in humans and other species ([@ref67]). Potentially, the thickness of the smooth muscle layer may be linked to the adrenergic receptor density and strength of stimulation ([@ref72]) and LTH in the fetal and adult periods may enhance adrenergic-mediated cellular hypertrophy and proliferation as occurs in cultured rat pulmonary arteries ([@ref14]). The influence of LTH on adrenergic stimulation may be similar to chronic intermittent hypoxia, which increases sympathetic nervous system outflow from the brainstem ([@ref75]). Neurohumoral modulatory pathways influenced by sympathetic stimulation include downregulation of nitric oxide (NO) signaling in the brain ([@ref55]) and upregulation of endothelin-1 ([@ref34]). Furthermore, physiological as well as psychological and environmental stresses are known to increase sympathetic nerve activity ([@ref2]). Chronic intermittent hypoxia also elicits chemosensory plasticity, including increased basal discharge, enhanced hypoxic sensitivity, and sensory long-term facilitation ([@ref56]). Even still, the effect of LTH in the fetal and adult periods in sheep is distinct from the adaptive responses in chick embryos. Chronic hypoxia in 19-day-old chick embryos reduces pulmonary arterial contractions due to high K^+^, norepinephrine, U46119, and endothelin-1, although there is no difference in the perivascular innervation density before birth and contraction deficits resolve after birth ([@ref69]). These distinctions in prenatal programming effects between fetal sheep versus chick embryos are not unfounded and follow from studies by us and others in the cardiovascular systems of these models ([@ref10]; [@ref69]; [@ref26]; [@ref6]; [@ref19]).

Adrenergic contraction of fetal pulmonary vessels involves all three α~1~-AR subtypes and was efficiently coupled to the contraction as PE stimulation produced about the same force as high K^+^. The role for α~2~-adrenoreceptors in the fetus was unanticipated as PE is fairly selective for the α~1~-AR; however, α~2~-ARs appear to be important for sympathetic pulmonary arterial contraction before birth and antenatal LTH attenuates their role in fetal vessels. Prior studies indicated that α~2~-ARs were expressed in the pulmonary vasculature and involved in arterial contractions, even before birth ([@ref44]; [@ref36]). Much like our studies, postnatal maturation seems to contribute to downregulation of α~2~-AR-mediated responses ([@ref64]).

Previous *in vitro* studies showed that vasodilation due to α~2~-AR activation resulted from endothelial NO release. NO-synthase inhibition not only abolished pulmonary vasodilator effects of α~2~-AR agonists but also unmasked their pulmonary vasoconstrictive function in rabbit pulmonary arteries where norepinephrine induced contractions were augmented through α~2~-AR-mediated mechanisms ([@ref43]). As α~2~-AR agonists may induce pulmonary arterial myocyte contraction ([@ref57]) in addition to relaxation, it is possible that pulmonary vascular responses to α~2~-AR result from the balance between the activation of α~1~- and α~2~-AR-induced smooth muscle cell contraction and endothelial α~2~-AR-mediated vasodilation ([@ref44]). Though further experiments will be required to directly address the α~2~-AR-mediated dilation we report in the sheep fetal vessels, we do not believe that this is due to incomplete disruption of the endothelium because bradykinin and acetylcholine have little or no effect on pulmonary arterial reactivity ([@ref6]; [@ref19]). Rather, preferential α~2~-AR reactivity in the normoxic fetus and not in other groups suggests that the role for this receptor is labile and greatly influenced by LTH in the fetal period and by postnatal development.

The simplest explanation for α~2~-AR-induced contractile effects is that stimulation of smooth muscle α~2~-ARs inhibits cAMP production *via* G~i~ coupling resulting in increased arterial reactivity. Indeed, there is precedent for direct α~2~-AR-dependent contraction in porcine pulmonary arteries where α~2~c-ARs mediate myocyte contraction when the cytosolic Ca^2+^ concentration is elevated. In these arteries, norepinephrine activates α~2~c-AR following α~1~-AR-stimulation and concomitant myocyte Ca^2+^ increases ([@ref36]). Such findings are not restricted to the pulmonary vasculature. In nasal mucosa blood vessels of pigs, which are richly innervated by sympathetic nerves, neurogenic vasomotor contractility is largely regulated through postjunctional α~2~-ARs ([@ref9]). The relaxation of serotonin preconstricted arteries by α~2~-AR activation may therefore be explained by varied expression of α~2~-AR subtypes or by postjunctional mechanisms. For example, in the pregnant rat myometrium, α~2A~- and α~2C~-AR activation causes myometrial relaxation, while α~2B~-AR stimulation elicits contraction. Thus, it is quite possible there are multiple α~2~-AR subtypes expressed in the pulmonary vasculature that serve distinct roles in regulating arterial relaxation and contraction, which are modified differentially by LTH in the fetal and adult periods ([@ref18]). Overall, the current experiments support previous studies suggesting that α~2~-ARs may modulate pulmonary vascular tone and that LTH influences receptor function in sheep vessels ([@ref44]; [@ref60]). Further investigation is required to fully delineate the importance of α~2~-ARs and the roles of prejunctional receptors on perivascular nerves as well as postjunctional receptors on smooth muscle or endothelium.

The present study evaluating α-adrenergic stimulation of the pulmonary vasculature parallels recent studies from our group focused on the cerebral vasculature that compared the effects of maturation and LTH in the fetal and adult periods ([@ref25], [@ref23]). The present study delineates that all three α~1~-AR subtypes are important to normoxic fetal sheep pulmonary arterial reactivity. This compares with normoxic fetal sheep cerebral arteries in which only the α~1B~ and α~1D~-AR regulate arterial contraction ([@ref25]). The importance of α~1~-AR subtypes in sheep adult cerebral vessels is also distinct from adult pulmonary vessels. Adult normoxic cerebral vessels are dependent on all three receptor subtypes, while LTH causes pronounced loss in α~1D~-AR function. Adult normoxic pulmonary arteries in comparison are reliant on α~1A~ and α~1B~-AR but not α~1D~-AR activity, and their relative roles are not greatly influenced by LTH. Overall, LTH appears to cause cerebral vessels to become more pulmonary-like in regards to the importance of α~1~-adrenergic receptor subtypes to arterial reactivity ([@ref23]).

Alpha-Adrenergic Receptor and Calcium Responses in Pulmonary Arterial Myocytes {#sec22}
------------------------------------------------------------------------------

Phenylephrine-induced Ca^2+^ signals in individual myocytes within intact arteries were examined to better understand the cellular mechanisms linking α~1~-AR stimulation to vascular reactivity. LTH in the fetal and adult periods caused complex changes in the Ca^2+^ signals. The modest phenylephrine Ca^2+^ activity responses in myocytes of pulmonary arteries from the fetal and adult periods together with the decrease in arterial reactivity relative to high K^+^ in the adult period suggest that arterial contractions in the fetal period are more sensitized to changes in the cytosolic Ca^2+^ concentration. Further, given the increase in arterial reactivity but lack of change in Ca^2+^ activity of arterial myocytes LTH may enhance the Ca^2+^ sensitivity in arterial myocytes from the adult period. Although not examined in the current study, previous work from our group illustrates that there are several intracellular signaling pathways that may be important to changes in the Ca^2+^ sensitivity. Previously, we have shown that rho-kinase is critical to serotonergic and depolarization-induced reactivity in sheep pulmonary arteries ([@ref53]; [@ref5]). Protein kinase C (PKC) and extracellular regulated kinase (ERK) pathways are also potentially involved as they are controlled by adrenergic receptor activity in cerebral and uterine arteries of sheep ([@ref71]; [@ref25]). In addition, in cerebral arteries from sheep, the different adrenergic receptor isoforms make varied linkages to Ca^2+^, PKC, and ERK pathways ([@ref41]; [@ref68]; [@ref24],[@ref25]), which can be modified in unique ways by LTH in the fetal and adult vessels. Elucidating the nuances associated with the changes due to LTH in the fetal and adult periods for the Ca^2+^ sensitization pathways was not addressed in these initial series of studies. However, based on our previous comparisons to vessels from other vascular beds in sheep, we anticipate the mechanistic modifications due to postnatal maturity and LTH to be distinct in the pulmonary vasculature.

Perspective {#sec23}
-----------

The molecular and signaling underpinnings of pulmonary vascular disease are complex. The evidence provided supports the vital role of LTH in the development of adrenergic-induced pulmonary hypertension and the variation in responsiveness due to development. Further, the data substantiate early studies suggesting that adrenergic receptor antagonists can be used to manage the disease ([@ref51]) in addition to recent porcine and canine studies ([@ref58]; [@ref74]) and a human clinical trial ([@ref8]) focusing on histological, hemodynamic, functional, and clinical benefits to denervation of the pulmonary vasculature. The long-term benefits of the present findings relate to the therapeutic potential of targeting adrenergic signaling in ways that curtail detriments in pulmonary vascular function due to high altitude or other mechanisms that enhance sympathetic drive.
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